Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity

Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity

Doxorubicin hydrochloride (DOX) is a well-known antitumor drug used as first line treatment for many types of malignancies. Despite its clinical relevance, the administration of the compound is negatively affected by dose-dependent off-target toxicity phenomena. Nanotechnology has helped to overcome...

Full description

Bibliographic Details
Main Authors: Silvia Voci, Agnese Gagliardi, Nicola Ambrosio, Maria Cristina Salvatici, Massimo Fresta, Donato Cosco
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Pharmaceutics
Subjects:
cancer
doxorubicin hydrochloride
drug delivery
gliadin
nanoparticles
proteins
Online Access:https://www.mdpi.com/1999-4923/15/1/180

Similar Items

Similar Items